Concepedia

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

Bengt I. Eriksson, O.E. Dahl, Harry R. Büller, Rohan Hettiarachchi, Nadia Rosencher, M-L. BRAVO, Lennart Ahnfelt, Franco Piovella, Joachim Stangier, P. KÄLEBO,

Journal of Thrombosis and Haemostasis · 2004 · 413 citations · 10 references

References

10

The Pharmacology and Management of the Vitamin K Antagonists

Jack Ansell, Jack Hirsh, L. Poller et al. · CHEST Journal · 2004 · 1.5K citations

Medicine, Pharmacology, Pharmacotherapy +9

Roentgen Diagnosis of Venous Thrombosis in the Leg

Keith Rabinov · Archives of Surgery · 1972 · 760 citations

Medicine, Radiology, Surgery +17

Ventilation-perfusion studies in suspected pulmonary embolism

DR Biello, AG Mattar, RC McKnight et al. · American Journal of Roentgenology · 1979 · 317 citations

Medicine, Clinical Sciences, Internal Medicine +16

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

Bengt I. Eriksson, Peter Kälebo, David Bergqvisty et al. · The Lancet · 2002 · 248 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

Bengt I. Eriksson, O.E. Dahl, Lennart Ahnfelt et al. · Journal of Thrombosis and Haemostasis · 2004 · 202 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15